Hansen Gwenn Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
29
Insider Sells Sum
$944,717.51

Insider Activity of Hansen Gwenn

According to the SEC Form 4 filings, Hansen Gwenn, being in a position of

  1. Chief Scientific Officer at Nurix Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 34130 shares for $757,805,
    over all time since 2021-02-18, has bought 0 shares, and sold 91548 shares for $1.81M.

Biography of Hansen Gwenn

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $757,80510100

Comparison of Insiders on Amount of Buys and Sells

2026-11-02SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
1,452
0.0014%
$26.80$38,914+0.47%
2026-10-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
3,957
0.0035%
$26.28$103,986-3.88%
2026-10-15SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
1,452
0.0014%
$25.00$36,300+3.49%
2026-09-01SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
1,452
0.0014%
$25.47$36,982-3.09%
2026-08-05SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
4,356
0.0042%
$25.00$108,900+1.71%
2026-08-04SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
4,111
0.0039%
$24.36$100,142+3.44%
2026-07-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
3,847
0.0037%
$23.38$89,954+8.23%
2026-06-25SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
5,394
0.0066%
$20.00$107,880+11%
2026-04-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
3,214
0.0037%
$16.65$53,498+41.74%
2026-01-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
4,895
0.0057%
$16.60$81,249+7.51%
2025-10-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
4,087
0.0065%
$12.80$52,300+41%
2025-07-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
4,308
0.0057%
$12.01$51,743+34.43%
2025-04-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
3,377
0.0044%
$11.50$38,841+8.76%
2025-01-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
3,690
0.0053%
$19.85$73,260-40.26%
2024-10-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
3,437
0.0049%
$24.30$83,536-50.37%
2024-07-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
3,408
0.0053%
$20.67$70,436-8.88%
2024-04-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
2,007
0.0034%
$12.04$24,169+66.64%
2024-01-30SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
2,334
0.0048%
$7.99$18,649+150.56%
2023-10-31SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
1,633
0.0031%
$5.20$8,487+165.74%
2023-07-31SaleNurix Therapeutics, Inc.
NRIX
Chief Scientific Officer
1,884
0.0035%
$9.65$18,189+0.05%
Total: 41
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.